Compile Data Set for Download or QSAR
Report error Found 14 Enz. Inhib. hit(s) with all data for entry = 12444
TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM703007(US20240366813, Compound E18)
Affinity DataKd:  0.00100nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM50544833(Vipivotide tetraxetan | PSMA-617 | US20240366813, ...)
Affinity DataKd:  0.00200nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM703012(US20240366813, Compound E25)
Affinity DataKd:  0.0710nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM703010(US20240366813, Compound E22)
Affinity DataKd:  0.100nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM703009(US20240366813, Compound E21)
Affinity DataKd:  0.151nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM703001(US20240366813, Compound E2)
Affinity DataKd:  0.229nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM703003(US20240366813, Compound E4)
Affinity DataKd:  0.269nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM703005(US20240366813, Compound E9)
Affinity DataKd:  0.282nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM703004(US20240366813, Compound E8)
Affinity DataKd:  0.324nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM703013(US20240366813, Compound E26)
Affinity DataKd:  0.363nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM703002(US20240366813, Compound E3)
Affinity DataKd:  0.550nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM703008(US20240366813, Compound E20)
Affinity DataKd:  0nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM703006(US20240366813, Compound E13)
Affinity DataKd:  0nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM703011(US20240366813, Compound E24)
Affinity DataKd:  0nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent